Evidences of CTLA-4 and PD-1 Blocking Agents-Induced Cardiotoxicity in Cellular and Preclinical Models

Background: Several strategies based on immune checkpoint inhibitors (ICIs) have been developed for cancer therapy, opening to advantages in cancer outcomes. However, several ICI-induced side effects have emerged in these patients, especially a rare but clinically significant cardiotoxicity with hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Quagliariello, Vincenzo, Passariello, Margherita, Rea, Domenica, Barbieri, Antonio, Iovine, Martina, Bonelli, Annamaria, Caronna, Antonietta, Botti, Gerardo, De Lorenzo, Claudia, Maurea, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711520/
https://www.ncbi.nlm.nih.gov/pubmed/33086484
http://dx.doi.org/10.3390/jpm10040179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711520/
https://www.ncbi.nlm.nih.gov/pubmed/33086484
http://dx.doi.org/10.3390/jpm10040179

Ejemplares similares